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CASE REPORT
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Abstract
Severe symptomatic tricuspid regurgitation (TR) remains an undertreated disease.
Multiple trans-catheter treatment options are currently under investigation. Transcatheter caval valve implantation (CAVI) has been utilized as a treatment option and
aims at decreasing or eliminating the caval backflow that occurs in severe TR
patients. Understanding challenges with this therapy is paramount. Hereby we present a CAVI case with resultant non-coaptation of valve leaflets in a patient with a
prominent Eustachian ridge.
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I N T RO DU CT I O N

despite maximal medical therapy and was deemed high risk for surgery given her multiple mentioned comorbidities. Decision was made

Severe symptomatic tricuspid regurgitation (TR) remains an under-

to pursue CAVI for symptom relief.

treated disease. Medical therapy is frequently ineffective and surgical

CAVI was performed with the standard technique.3 Briefly, utilizing

treatment is associated with morbidity and mortality and many patients

an externalized Nitrix wire from the right femoral vein to the right inter-

are not surgical candidates.1 Multiple trans-catheter treatment options

nal jugular vein a 35 mm Cook-Z® stent (Cook Medical LLC, Blooming-

are currently under investigation.2 Transcatheter caval valve implanta-

ton IN) was deployed in the right atrial (RA)/inferior vena cava (IVC)

tion (CAVI) has been utilized as a treatment option and aims at decreas-

junction with the help of a Reliant balloon from right internal jugular

ing or eliminating the caval backflow that occurs in severe TR patients.

vein for stabilization of the stent. A 29 mm Edwards Sapien valve

Understanding challenges with this therapy is paramount. Hereby we

(Edwards Lifesciences, California) was deployed inside the Cook-Z®

present a CAVI case with resultant non-coaptation of valve leaflets in a

stent just superior to the most superior hepatic vein resulting in acute

patient with a prominent Eustachian ridge.

reduction in IVC regurgitation (Video 1). Intra-procedurally, there was
decreased leaflet motion on the new valve that completely resolved
with fluid administration (Video 2). However, on follow up in clinic after

2

|

CASE REPORT

4 weeks her ascites and lower extremity edema did not improve and
thus a repeat gated CTA with CAVI protocol was done. CTA showed

The patient is a 45 year-old woman with severe functional TR, non-

that the transcatheter heart valve leaflets were not fully coapting, with

ischemic cardiomyopathy, end stage renal disease s/p kidney and pan-

the posterior leaflet demonstrating the most malcoaptation (Figures 1

creatic transplant 10 years ago complicated by post transplant lym-

and 2, and Video 3) and that there was severe residual regurgitation to

phoproliferative disease and large B cell lymphoma treated with

the IVC and hepatic veins. Further review of the 4D CT demonstrated

chemotherapy, pulmonary embolism and recurrent gastrointestinal

the TR jet was directed away from the IVC by a prominent Eustachian

bleeding. She had suffered from recurrent heart failure admissions,

ridge which was buttressed by the Z-stent. Normally, this TR jet would

ascites and severe lower extremity edema secondary to her severe TR

aid in closing the Sapien leaflets in systole; however, in this case
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F I G U R E 1 Impact of Eustachian ridge on tricuspid regurgitation (TR) jet direction as seen on CT and in virtual 3D model from CT. (Panel A)
Three solid purple arrows illustrates the position of the eustachian ridge that extends from the ostium of the IVC into the inferior rim of the right
atrium. Orange arrow: depicts turbulent flow pathway of tricuspid regurgitation from right atrium (RA) into the inferior vena cava (IVC) away from
the eustachian ridge. Solid red arrow in Panel A sagittal cross section demonstrates impaired closure of all caval valve leaflets, with the posterior
leaflet of the caval valve most affected causing eccentric wide open reflux of tricuspid regurgitation into the IVC. Panel B demonstrates the 3D
virtual CT model of the caval valve implant, illustrating the deformation of the atrial portion of the Z-stent by the prominent eustachian ridge
(outlined in peach color). Purple arrows in panel B corresponds to the most posterior-medial aspect of the eustaschian ridge as it forms the
junction of the IVC to the RA [Color figure can be viewed at wileyonlinelibrary.com]

F I G U R E 2 Impact of Eustachian ridge on tricuspid regurgitation (TR) jet direction. (Panel A) Three solid pruple arrows illustrates the position
of the eustachian ridge that extends from the ostium of the inferior vena cava (IVC) into the inferior rim of the right atrium. Orange arrow: depicts
turbulent flow pathway of tricuspid regurgitation from right atrium (RA) into the IVC away from the eustachian ridge. Solid red arrow in Panel A
sagittal cross section and Panel B Axial cross-section of the 29S3 implanted in the caval position demonstrates impaired closure of all three caval
leaflets, with the posterior leaflet of the caval valve most affected causing eccentric wide open reflux of tricuspid regurgitation into the IVC [Color
figure can be viewed at wileyonlinelibrary.com]
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obstruction of retrograde flow from the RA into the IVC by the pres-

Dr. Brian O'Neill is a consultant and receives research funding from

ence of a prominent eustachian ridge resulted in eccentric flow of the

Edwards Lifesciences. The remaining authors have no relevant

TR jet directed away from the IVC; thereby restricting leaflet motion of

relationships to disclose.

the caval valve implant. Due to the presence of the prominent RA-IVC
cresenteric eustachian ridge, the eccentric tricuspid regurgitant jet is
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directed toward the posterior-septal portion of the right atrium, and

The data that support the findings of this study are available from the

eccentrically continuing toward the anterior portion of the IVC, thereby

corresponding author upon reasonable request.

unevenly distributing the pressure gradient across the three leaflets of
the transcatheter heart valve. The uneven distribution of the resulting
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pressure gradient of the tricuspid regurgitant jet in the IVC led to
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CAVAL valve implantation. Interestingly, pre procedural right heart
catheterization showed an IVC pressure of 14 mmHg and a superior
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DISCUSSION AND CONCLUSION

Our case emphasizes the importance of TR flow directionality in relation
to the implanted caval Sapien valve that we are hypothesizing lead to
the early failure of the caval valve. Other causes for transcatheter heart
valve leaflet restriction include: (a) thrombus formation (CT did not show
any evidence of this) and (b) technical issues with the transcatheter
valve or the Z stent. In patients who undergo CAVI, attention should be
paid to minimize the amount of scaffolding which is present in the right

SUPPORTING INF ORMATION
Additional supporting information may be found online in the
Supporting Information section at the end of this article.

atrium to avoid this potential challenge. Those patients without adequate distance from the superior hepatic vein to the RA/caval junction
should be deferred. The effect of prominent Eustachian ridge on out-
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comes in CAVI procedures should be further studied and proven.
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